Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carpinus caroliniana pollen is an allergen extract derived from the American hornbeam tree, also known as blue-beech or ironwood. It is primarily used as a diagnostic biological product in allergy testing to identify hypersensitivity in patients with suspected allergic rhinoconjunctivitis or other pollen-related conditions. The extract contains the naturally occurring proteins from the pollen of the Carpinus caroliniana plant. When administered via skin prick or intradermal testing, the allergens in the extract cross-link specific IgE antibodies on the surface of mast cells and basophils, triggering the release of histamine and other inflammatory mediators that produce a visible wheal-and-flare reaction in sensitized individuals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carpinus caroliniana pollen.